We can assist you in the development and evaluation of novel (immuno-)oncology therapies, from PoC studies, efficacy evaluation, biodistribution, MoA investigation, Toxicology/PK analyses to the development of standard-of-care resistant models, we have over 150 CDX, PDX and syngeneic models to meet all your needs. Our expert scientists are ready to propel your anti-cancer therapies forward! Exclusively for new customers!